- Home
- ONEG vs PEPG Comparison
ONEG vs PEPG Comparison
Compare ONEG & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- PEPG
- Stock Information
- Founded
- ONEG 2021
- PEPG 2018
- Country
- ONEG Hong Kong
- PEPG United States
- Employees
- ONEG N/A
- PEPG N/A
- Industry
- ONEG Homebuilding
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- PEPG Health Care
- Exchange
- ONEG Nasdaq
- PEPG Nasdaq
- Market Cap
- ONEG 43.3M
- PEPG 43.2M
- IPO Year
- ONEG 2024
- PEPG 2022
- Fundamental
- Price
- ONEG $5.81
- PEPG $1.37
- Analyst Decision
- ONEG
- PEPG Buy
- Analyst Count
- ONEG 0
- PEPG 3
- Target Price
- ONEG N/A
- PEPG $7.67
- AVG Volume (30 Days)
- ONEG 25.8K
- PEPG 158.8K
- Earning Date
- ONEG 01-01-0001
- PEPG 08-15-2025
- Dividend Yield
- ONEG N/A
- PEPG N/A
- EPS Growth
- ONEG N/A
- PEPG N/A
- EPS
- ONEG 0.12
- PEPG N/A
- Revenue
- ONEG $60,903,000.00
- PEPG N/A
- Revenue This Year
- ONEG N/A
- PEPG N/A
- Revenue Next Year
- ONEG N/A
- PEPG N/A
- P/E Ratio
- ONEG $46.63
- PEPG N/A
- Revenue Growth
- ONEG 16.46
- PEPG N/A
- 52 Week Low
- ONEG $1.48
- PEPG $0.88
- 52 Week High
- ONEG $10.80
- PEPG $10.15
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- PEPG 52.16
- Support Level
- ONEG N/A
- PEPG $1.37
- Resistance Level
- ONEG N/A
- PEPG $1.46
- Average True Range (ATR)
- ONEG 0.00
- PEPG 0.09
- MACD
- ONEG 0.00
- PEPG -0.00
- Stochastic Oscillator
- ONEG 0.00
- PEPG 54.55
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.